PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 170 filers reported holding PTC THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,389,000 | -73.2% | 29,556 | -80.8% | 0.06% | -70.1% |
| Q2 2018 | $5,192,000 | +34.2% | 153,956 | +7.7% | 0.21% | +36.1% |
| Q1 2018 | $3,868,000 | +61.2% | 142,956 | -0.6% | 0.16% | +46.2% |
| Q4 2017 | $2,399,000 | +166.3% | 143,863 | +219.2% | 0.11% | +130.4% |
| Q3 2017 | $901,000 | +3.1% | 45,063 | -49.3% | 0.05% | +15.0% |
| Q1 2017 | $874,000 | -36.3% | 88,889 | -29.3% | 0.04% | -51.2% |
| Q4 2016 | $1,371,000 | +30.9% | 125,700 | -15.7% | 0.08% | +57.7% |
| Q2 2016 | $1,047,000 | -25.8% | 149,159 | -32.0% | 0.05% | -17.5% |
| Q1 2016 | $1,412,000 | +30.6% | 219,388 | +792.9% | 0.06% | +26.0% |
| Q3 2014 | $1,081,000 | – | 24,570 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |